The effect of C1 inhibitor on myocardial ischemia and reperfusion injury

Cardiovascular Pathology

Volumn 22, Issue 1, 2013, Pages 75-80

  Lu, Fengxin ^a   Fernandes, Stacey M ^a   Davis III, Alvin E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Complement inhibition; Leukocyte transmigration; Myocardial ischemia and reperfusion

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE SIZE; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; CHEMOTAXIS, LEUKOCYTE; COMPLEMENT ACTIVATION; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C3; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHIL INFILTRATION; TROPONIN I;

EID: 84870890596     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2012.05.003     Document Type: Article

References (52)

1. American Heart Association Heart disease and stroke statistics 2010 update: a report from the American Heart Association Circulation 121 7 2010 e46 e215
2. C. Duilio, G. Ambrosio, P. Kuppusamy, A. Dipaula, L.C. Becker, and J.L. Zweier Neutrophils are primary source of O2 radical during reperfusion after prolonged myocardial ischemia Am J Physiol Heart Circ Physiol 280 6 2001 H2649 H2657
3. B.R. Lucchesi Complement, neutrophils and free radicals: mediators of reperfusion injury Arzneim-Forsch/Drug Res 44 3A 1994 420 432 (Pubitemid 24101105)
4. J.H. Hill, and P.A. Ward The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats J Exp Med 133 4 1971 885 900
5. M. Griselli, J. Herbert, and W.L. Hutchinson C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 190 12 1999 1733 1740
6. F. Hugo, T. Hamdoch, D. Mathey, H. Schäfer, and S. Bhakdi Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium Clin Exp Immunol 81 1 1990 132 136 (Pubitemid 20229712)
7. W.K. Lagrand, H.W. Niessen, and G.J. Wolbink C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction Circulation 95 1 1997 97 103 (Pubitemid 27029949)
8. D. Mathey, J. Schofer, and H.J. Schäfer Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion Eur Heart J 15 3 1994 418 423 (Pubitemid 24127392)
9. M. Buerke, T. Murohara, and A.M. Lefer Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion Circulation 91 2 1995 393 402
10. M. Buerke, H. Schwertz, W. Seitz, J. Meyer, and H. Darius Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits J Immunol 167 9 2001 5375 5380 (Pubitemid 33009777)
11. G. Horstick, A. Heimann, and O. Götze Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion Circulation 95 3 1997 701 708 (Pubitemid 27063048)
12. A.P. Vakeva, A. Agah, S.A. Rollins, L.A. Matis, L. Li, and G.L. Stahl Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy Circulation 97 22 1998 2259 2267 (Pubitemid 28265388)
13. H.F. Weisman, T. Bartow, and M.K. Leppo Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis Science 249 4965 1990 146 151
14. x Br J Pharmacol 128 5 1999 945 952 (Pubitemid 29512026)
15. M.L. Entman, L. Michael, and R.D. Rossen Inflammation in the course of early myocardial ischemia FASEB J 5 11 1991 2529 2537 (Pubitemid 21905802)
16. D.N. Granger, and P. Kubes The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion J Leukoc Biol 55 5 1994 662 675 (Pubitemid 24171735)
17. J.E. Jordan The role of neutrophils in myocardial ischemia-reperfusion injury Cardio Res 43 4 1999 860 878 (Pubitemid 29413185)
18. H. Jiang, E. Wagner, H. Zhang, and M.M. Frank Complement 1 inhibitor is a regulator of the alternative complement pathway J Exp Med 194 11 2001 1609 1616 (Pubitemid 33126811)
19. S.V. Petersen, S. Thiel, L. Jensen, T. Vorup-Jensen, C. Koch, and J.C. Jensenius Control of the classical and the MBL pathway of complement activation Mol Immunol 37 14 2000 803 811
20. N.K.H. Wong, M. Kojima, J. Dobo, G. Ambrus, and R.B. Sim Activities of the MBL-associated serine proteases (MASPs) and their regulation by natural inhibitors Mol Immunol 36 13-14 1999 853 861 (Pubitemid 30100837)
21. C. Caliezi, W.A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C.E. Hack C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema Pharmacol Rev 52 1 2001 91 112 (Pubitemid 30127596)
22. P.A. Pemberton, R.A. Harrison, P.J. Lachmann, and R.W. Carrell The structural basis for neutrophil inactivation of C1 inhibitor Biochem J 258 1 1989 193 198 (Pubitemid 19062269)
23. R. Bauernschmitt, H. Bohrer, and S. Hagal Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA Intensive Care Med 24 6 1998 635 638 (Pubitemid 28344770)
24. C. de Zwaan, A.H. Kleine, and J.H. Diris Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction Eur Heart J 23 21 2002 1670 1677 (Pubitemid 36287778)
25. K. Fattouch, G. Bianco, and G. Speziale Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study Eur J Cardiothorac Surg 32 2 2007 326 332 (Pubitemid 47021452)
26. F. Lu, A.K. Chauhan, S.M. Fernandes, M.T. Walsh, D.D. Wagner, and A.E. Davis The effect of C1 inhibitor on intestinal ischemia and reperfusion injury Am J Physiol Gastrointest Liver Physiol 295 5 2008 G1042 G1049
27. S. Cai, V.S. Dole, and W. Bergmeier A direct role for C1 inhibitor in regulation of leukocyte adhesion J Immunol 174 10 2005 6462 6466 (Pubitemid 40663841)
28. E.D. Han, R.C. MacFarlane, A.N. Mulligan, J. Scafidi, and A.E. Davis Increased vascular permeability in C1 inhibitor-deficient mice is mediated by the bradykinin type 2 receptor J Clin Invest 109 8 2002 1057 1063 (Pubitemid 34408580)
29. K.S. Aulak, and R.S. Harrison Rapid and sensitive techniques for identification and analysis of 'reactive-centre' mutants of C1-inhibitor proteins contained in type II hereditary angio-oedema plasmas Biochem J 271 3 1990 565 569 (Pubitemid 20384584)
30. T.V. Arumugam, I.A. Shiels, A.J. Strachan, G. Abbenante, D.P. Fairlie, and S.M. Taylor A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats Kidney Int 63 1 2003 134 142 (Pubitemid 35463914)
31. H. Jaeschke, A. Farhood, A.P. Bautista, Z. Spolarics, and J.J. Spitzer Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia Am J Physiol Gastrointest Liver Physiol 264 4 1993 G801 G809
32. G.L. Stahl, Y. Xu, and L. Hao Role for the alternative complement pathway in ischemia/reperfusion injury Am J Pathol 162 2 2003 449 455 (Pubitemid 36267852)
33. W.B. Gorsuch, B.J. Guikema, D.C. Fritzinger, C.W. Vogel, and G.L. Stahl Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury Mol Immunol 47 2-3 2009 506 510
34. P.R. Maroko, C.B. Carpenter, and M. Chiariello Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion J Clin Invest 61 3 1978 661 670
35. M. Buerke, D. Prüfer, M. Dahm, H. Oelert, J. Meyer, and H. Darius Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury J Pharmacol Exp Ther 286 1 1998 429 438 (Pubitemid 28318019)
36. G. Horstick, O. Berg, and A. Heimann Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects Circulation 104 25 2001 3125 3131 (Pubitemid 34014069)
37. J.A. Huntington, R.J. Read, and R.W. Carrell Structure of a serpin-protease complex shows inhibition by deformation Nature 407 6806 2000 923 926
38. P.A. Patston, P. Gettins, J. Beechem, and M. Schapira Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate Biochemistry 30 36 1991 8876 8882
39. M. Kirschfink, and W. Nürnberger C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application Mol Immunol 36 4-5 1999 225 232 (Pubitemid 29281850)
40. P.R. Hansen Role of neutrophils in myocardial ischemia and reperfusion Circulation 91 6 1995 1872 1885
41. B.R. Lucchesi, S.W. Werns, and J.C. Fantone The role of the neutrophil and free radicals in ischemic myocardial injury J Mol Cell Cardiol 21 12 1989 1241 1251 (Pubitemid 20046099)
42. M.R. Hoffmeyer, R. Scalia, C.R. Ross, S.P. Jones, and D.J. Lefer PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice Am J Physiol Heart Circ Physiol 279 6 2000 H2824 H2828
43. H. Kin, N.P. Wang, M.E. Halkos, F. Kerendi, R.A. Guyton, and Z.Q. Zhao Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/TNFalpha release after ischemia and reperfusion J Surg Res 135 1 2006 170 178 (Pubitemid 44215908)
44. W.J. Dreyer, L.H. Michael, and M.S. West Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion Circulation 84 1 1991 400 401
45. E.M. Boyle, T.H. Pohlman, C.J. Cornejo, and E.D. Verrier Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion Ann Thorac Surg 62 6 1996 1868 1875 (Pubitemid 26421144)
46. A.M. Lefer, P.S. Tsao, D.J. Lefer, and X.-L. Ma Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia FASEB J 5 7 1991 2029 2034 (Pubitemid 121000166)
47. A.M. Lefer, X.-L. Ma, A. Weyrich, and D.J. Lefer Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury Agents Actions Suppl 41 1993 127 135 (Pubitemid 23149622)
48. R.P. McEver, and R.D. Cummings Role of PSGL-1 binding to selectins in leukocyte recruitment J Clin Invest 100 3 1997 485 492 (Pubitemid 27340493)
49. K.L. Moore, K.D. Patel, and R.E. Bruehl P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin J Biol 128 4 1995 661 671
50. S.P. Jones, W.G. Girod, and A.J. Palazzo Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase Am J Physiol Heart Circ Physiol 276 5 1999 H1567 H1573
51. A.J. Palazzo, S.P. Jones, D.C. Anderson, D.N. Granger, and D.J. Lefer Coronary endothelial P-selectin in pathogenesis of myocardial ischemia-reperfusion injury Am J Physiol Heart Circ Physiol 275 5 1998 H1865 H1872
52. A.J. Palazzo, S.P. Jones, W.G. Girod, D.C. Anderson, D.N. Granger, and D.J. Lefer Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice Am J Physiol Heart Circ Physiol 275 6 1998 H2300 H2307